A detailed history of Legato Capital Management LLC transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Legato Capital Management LLC holds 54,903 shares of PCRX stock, worth $1.13 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
54,903
Previous 52,913 3.76%
Holding current value
$1.13 Million
Previous $1.51 Million 45.41%
% of portfolio
0.11%
Previous 0.21%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$11.7 - $28.46 $23,283 - $56,635
1,990 Added 3.76%
54,903 $826,000
Q2 2024

Jul 26, 2024

BUY
$25.5 - $31.51 $573,673 - $708,880
22,497 Added 73.96%
52,913 $1.51 Million
Q1 2024

Apr 15, 2024

BUY
$27.7 - $35.48 $533,169 - $682,919
19,248 Added 172.35%
30,416 $888,000
Q4 2023

Jan 16, 2024

BUY
$26.32 - $34.31 $41,138 - $53,626
1,563 Added 16.27%
11,168 $376,000
Q3 2023

Oct 12, 2023

BUY
$30.68 - $40.09 $294,681 - $385,064
9,605 New
9,605 $294,000

Others Institutions Holding PCRX

About Pacira BioSciences, Inc.


  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $946M
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track Legato Capital Management LLC Portfolio

Follow Legato Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legato Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Legato Capital Management LLC with notifications on news.